Skip to content
To the full analysis

STAAR Surgical stock: balance sheet and debt

STAA
$26.78Closing price of 12 Nov 2026MEQIRI Score 44 out of 100

STAAR Surgical has a debt to equity ratio of 0.11.

Daily figure as of 13 Nov 2026

Debt / Equity
0.11
Interest coverage
no data
Current ratio
4.55
Cash & equivalents
$187.54M
Total assets
$461.62M
Equity ratio
74.6%
Goodwill
$1.79M
Plus intangible assets of $30.7M
Net debt
−$149.18M
More cash than debt

Total assets and equity ratio

How large the balance sheet of STAAR Surgical Company is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2006$47.77M$11.97M$7.53M66.5%−$4.65M
2007$54.18M$11.49M$7.53M66.9%−$4.75M
2008$52.58M$13.15M$7.54M30.5%$3.77M
2009$58.68M$12.03M$7.88M35.9%$2.23M
2010$40.59M$5.46M$1.79M55.3%−$5.08M
2011$49.01M$4.78M$1.79M60.1%−$12.28M
2012$54.76M$3.93M$1.79M58.0%−$14.51M
2013$61.93M$3.17M$1.79M62.7%−$17.78M
2014$58.91M$2.66M$1.79M63.0%−$8M
2015$62.95M$2.45M$1.79M61.7%−$8.68M
2016$65.44M$2.26M$1.79M57.9%−$7.18M
2017$67.93M$2.06M$1.79M63.2%−$12.27M
2018$167.34M$2.03M$1.79M79.1%−$98.54M
2019$207.52M$2.08M$1.79M77.0%−$110.43M
2020$257.42M$2.06M$1.79M76.6%−$141.65M
2021$345.78M$2M$1.79M74.8%−$167.65M
2022$418.82M$1.96M$1.79M80.3%−$180.6M
2023$488.69M$1.79M$1.79M79.0%−$184.89M
2024$509.52M$1.79M$1.79M78.0%−$191.75M
2025$461.62M$32.49M$1.79M74.6%−$149.18M

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2006$7.91M$31.76M$3.26M0.1
2007$11.05M$36.23M$6.3M0.17
2008$5.17M$16.03M$8.94M0.56
2009$6.33M$21.07M$8.56M0.41
2010$9.38M$22.43M$4.29M0.19
2011$16.58M$29.46M$4.3M0.15
2012$21.68M$31.74M$7.17M0.23
2013$22.95M$38.85M$5.18M0.13
2014$13.01M$37.1M$5.02M0.14
2015$13.4M$38.85M$4.73M0.12
2016$14M$37.91M$6.82M0.18
2017$18.52M$42.94M$6.25M0.15
2018$103.88M$132.43M$5.34M0.04
2019$119.97M$159.88M$9.54M0.06
2020$152.45M$197.22M$10.8M0.05
2021$199.71M$258.56M$32.06M0.12
2022$211.64M$336.11M$31.04M0.09
2023$220.73M$385.95M$35.83M0.09
2024$230.49M$397.34M$38.74M0.1
2025$187.54M$344.18M$38.35M0.11

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 2 Jan 2026
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 21 Feb 2025)
  • Valuation signal Overvalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy